4/1/2024 0 Comments Moca test score 20![]() The Alzheimer’s Disease Cooperative Study. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer’s Disease Assessment Scale that broaden its scope. H., Ernesto, C., Grundman, M., Sano, M., Bieliauskas, L., Geldmacher, D., Clark, C., & Thal, L. For other uses, please contact the original authors to seek permission. ![]() Training is required and can be obtained from the authors or from the Alzheimer’s Disease Cooperative Study.įree of charge to healthcare professionals for non-commercial clinical or research purposes. The ADAS-COG is administered by a neuropsychologist or psychologist. ADAS-COG is widely used as an outcome measure in drug and therapy treatments aimed at delaying cognitive decline in dementia. It is recommended for second-stage or in-depth assessments and/or for particular research evaluations rather than for applications in routine care settings. The ADAS-COG is used for comprehensive cognitive assessment. ![]() Cognitive Tests to Detect Dementia: A Systematic Review and Meta-analysis. Dementia and Geriatric Cognitive Disorders, 36(3–4), 242. Validation of the Addenbrooke’s Cognitive Examination III in frontotemporal dementia and Alzheimer’s disease. Hsieh, S., Schubert, S., Hoon, C., Mioshi, E., & Hodges, J.The ACE-III can be used for free in clinical practice and research projects. The ACE-III is administered by healthcare professionals. It is useful for differential diagnosis between Alzheimer’s disease (AD), frontotemporal dementia (FTD), Parkinson’s disease dementia and related neurodegenerative conditions. Thus, further research is needed to compare the MoCA to full neuropsychological assessments in this population.Īthletes Cognitive assessment tool Concussion Montreal Cognitive Assessment Sport-related concussion.The ACE-III is a comprehensive screening tool that is the recommended instrument for all dementias when shorter screens are inconclusive. In the appropriate clinical context, cognitive screening with the MoCA may benefit clinical care in athletes with multiple previous SRC, but should not replace a full neuropsychological assessment. ![]() Age, SP, and concussion modifiers (migraine, depression, anxiety, and attention deficit and hyperactivity disorder) did not influence the relationship between MoCA and previous concussion history. There was a significant relationship between the number of previous concussions and the MoCA subscales of attention (p = 0.05) and abstraction (p = 0.003). Males were 2.23 times more likely to have MCI than females (p = 0.0004). Logistic regression analysis was used to examine the association between the total MoCA score, MoCA subscales, and number of previous SRC, adjusting for age, sex, sport participation (SP), and concussion modifiers.Īthletes with a history of three or more SRC were 5.36 times more likely to score less than 26/30 on the MoCA (the cutoff for MCI) compared to athletes with two or less SRC (p = 0.02). We aimed to determine whether a sport-related concussion (SRC) history and other concussion modifiers influence global cognitive function in high-performance athletes.Ī cross-sectional study of 326 varsity and national team athletes aged 18-36 years was completed at the University of Calgary Sports Medicine Clinic, Calgary, Alberta, Canada. The Montreal Cognitive Assessment (MoCA) is a cognitive screening tool known to accurately measure mild cognitive impairment (MCI) in many different neurological populations.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |